Loading clinical trials...
Loading clinical trials...
A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee
This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.
Age
18 - 59 years
Sex
ALL
Healthy Volunteers
No
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Grossmont Orthopedic Medical Group
La Mesa, California, United States
Orthopaedic Specialty Institute/Newport Orthopedic Institute (OSI/NOI)
Orange, California, United States
UCSF Mission Bay Orthopaedic Institute
San Francisco, California, United States
Southern California Orthopedic Research and Education
Van Nuys, California, United States
Colorado University Boulder
Boulder, Colorado, United States
Steadman Hawkins Clinic - Denver
Denver, Colorado, United States
Shrock Clinical Research
Fort Lauderdale, Florida, United States
Jewett Orthopaedic Clinic
Orlando, Florida, United States
Optim Healthcare
Savannah, Georgia, United States
Start Date
May 1, 2010
Primary Completion Date
March 1, 2019
Completion Date
March 1, 2019
Last Updated
March 29, 2019
245
ACTUAL participants
NeoCart
BIOLOGICAL
Microfracture
PROCEDURE
Lead Sponsor
Histogenics Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions